胺碘酮联合美托洛尔静脉注射治疗快速心律失常的临床.docxVIP

胺硬酮联合美托洛尔静脉注射治疗快速心律失常的临床观察 摘要：目的，对在治疗快速心律失常时联合采用胺跳AH与美托洛尔的疗效与平安性.进行观 察和评价.方法：随机选择我院收治的90例快速心律失常患者，将其分为对照组和观察组 两组，每组各45例患者。在对照组使用胺碘酮进行治疗，而旦观察组那么采用胺娘国与美托 洛尔联合治疗。从疗效与不良反响两个方面，分析两组患者治疗效果差异。结果：就治疗有 效率和心率转夏率而言，观察组明显优于对照组，两组差异比拟有统计学意义(P<0.05)； ±±().5)h.P<0.05]o另外，对照组在 收缩压、舒张压、心率下降幅度等方面都逊于规耕组,严重不良反响案例在两组患者身上都 没有发生.结论：在静脉注射治疗快速心律失常时，采用胺碘桐联合美洛托尔联合治疗具有 平安、有效等优势，因此，该治疗方式值得在临床中推荐。 Clinical observation of amiodarone combined with metoprolol intravenous injection intreatment of tachyarrhythmia Abstract: Objective: to in the treatment of rapid arrhythmia with the efficacy and safety of amiodarone and melopnilol were observed and evaluated. Methods: 90 patients wilh arrhythmia were randomly selected and divided into control group and observation group, 45 cases in each group, two cases in each group. In the control group were treated with amiodarone, and the obsenation group was treated with amiodarone combined with metoprolol in the treatment of. From two aspects of efficacy and adverse reactions, analysis of two groups of patients with (reatinent effect differences. Results: (he efiective rate of treatment and (he rate of heart rate, the observation group was significantly belter (han the control group, the difference between the two groups was statistically significant (P<0.05); and in the onset lime, the observation group was better than the control group (0.4 + 0.5h). P<0.05]. In addition, the control group in systolic blood pressure, diastolic blood pressure, heart rate decreased and better (han the observation group. Severe adverse reactions in the two groups of patients did noi occur. (Conclusion: intravenous injeciion in the (reatmeni of rapid arrhythmia with amiodarone combined with meloxicain Thor combination therapy is safe and effective and other advantages. Therefore, the treatment is worth in clinical promotion. 作为常见多发疾病，快速心律失常包括房性心动过速、交界性心动过速、室性心动过速。 选择平安、仃效的抗心律失常药物是治疗快速心律失常的关键环节之」七它在减少急性并 发症、维持血流动力学毯定等方面.具有重要作用。虽然许多临床结果己经说明，胺碘酮对 治疗各种心律失常疗效非同小可，但是许多案例也显示它存在即时疗效欠佳的缺陷